UK markets closed

Galmed Pharmaceuticals Ltd. (GPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2420-0.0360 (-12.95%)
At close: 08:00AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-6,357
-6,912
-17,866
-32,467
-28,771
-
Depreciation & amortisation
32
31
35
42
39
-
Stock-based compensation
748
892
1,296
1,886
2,066
-
Change in working capital
-550
132
-2,451
-2,450
1,070
-
Accounts payable
-883
-681
-2,311
-2,175
1,047
-
Other working capital
-6,272
-6,137
-18,505
-32,903
-26,331
-
Other non-cash items
125
-47
-36
13
-254
-
Net cash provided by operating activities
-6,272
-6,137
-18,501
-32,892
-26,287
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-4
-11
-44
-12
Acquisitions, net
-
-1,500
0
0
-
-
Purchases of investments
-6,463
-6,333
-3,873
-13,569
-55,034
-
Sales/maturities of investments
7,844
8,633
21,440
25,043
71,614
-
Other investing activities
-
-
-
-1
-
-
Net cash used for investing activities
-119
800
17,563
11,462
16,536
-
Cash flows from financing activities
Common stock issued
-
6,185
70
17,368
707
-
Net cash used provided by (used for) financing activities
-
6,185
70
17,368
768
-
Net change in cash
-206
848
-868
-4,062
-8,983
-
Cash at beginning of period
1,786
2,130
2,998
7,060
16,043
-
Cash at end of period
1,580
2,978
2,130
2,998
7,060
-
Free cash flow
Operating cash flow
-6,272
-6,137
-18,501
-32,892
-26,287
-
Capital expenditure
-
-
-4
-11
-44
-12
Free cash flow
-6,272
-6,137
-18,505
-32,903
-26,331
-